Mar
13
2026

ERDERA interview with Bojana Mirosavljevic, rare disease patient advocate from Serbia and founder and president of Život/Life.

Bojana Mirosavljevic
A rare disease patient advocate reflects on Zoya’s Law, early diagnosis, and why patients are a crucial stakeholder in research, policy, and national rare disease systems.

News & Updates

You might also be interested in

From 25–28 May in Barcelona, the EURORDIS-led Open Academy x ERDERA Schools will bring patient advocates and early-career researchers together for four days of rare disease training, exchange and peer learning.
A new online learning series for ERN professionals, clinicians, researchers, and stakeholders.
Children, Young People and Family Involvement and Engagement Strategy 2024-2029